Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001615774-18-000382

Chief Executive Officer disposed of 171,832 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Silvers Daniel B. Chief Executive Officer 2018-01-15 Other disposition −171,832 1,128,370 I
Loading xslF345X03/s108737_form4.xml…